Previous Close | 348.15 |
Open | 347.22 |
Bid | 346.50 x 800 |
Ask | 348.09 x 800 |
Day's Range | 344.17 - 349.94 |
52 Week Range | 334.54 - 541.21 |
Volume | |
Avg. Volume | 2,005,046 |
Market Cap | 41.853B |
Beta (5Y Monthly) | 0.45 |
PE Ratio (TTM) | 17.36 |
EPS (TTM) | 20.00 |
Earnings Date | Apr 24, 2024 |
Forward Dividend & Yield | 3.54 (1.02%) |
Ex-Dividend Date | Mar 27, 2024 |
1y Target Est | 408.44 |
Subscribe to Yahoo Finance Plus to view Fair Value for HUM
LOUISVILLE, Ky., March 13, 2024--Humana Inc. (the "company") (NYSE: HUM) announced today the completion of its public offering of $2.25 billion in aggregate principal amount of senior notes. These senior notes are comprised of $1.25 billion of the company’s 5.375 percent senior notes, due 2031, at 99.940 percent of the principal amount, and $1.00 billion of the company’s 5.750 percent senior notes, due 2054, at 99.949 percent of the principal amount (collectively, the "Senior Notes Offerings").
OLDWICK, N.J., March 13, 2024--AM Best has assigned Long-Term Issue Credit Ratings (Long-Term IRs) of "bbb" (Good) to Humana Inc.’s (Humana) (headquartered in Louisville, KY) [NYSE: HUM] recently announced $1.25 billion 5.375% senior unsecured notes, due 2031, and $1 billion 5.75% senior unsecured notes, due 2054. In addition, AM Best has assigned indicative Long-Term IRs of "bbb" (Good) to senior unsecured issues, "bbb-" (Good) to subordinated issues and "bb+" (Fair) to preferred stock and of t
Health stocks are off to their best start since 2017, despite a history of underperformance in election years.